Frontiers in Molecular Neuroscience · 2018 · 25 citations · 82 references
Sepsis and metabolic syndrome (MetS) are both inflammation-related entities with high impact for human health and the consequences of concussions. Both represent imbalanced parasympathetic/cholinergic response to insulting triggers and variably uncontrolled inflammation that indicates shared upstream regulators, including short microRNAs (miRs) and long non-coding RNAs (lncRNAs). These may cross talk across multiple systems, leading to complex molecular and clinical outcomes. Notably, biomedical and RNA-sequencing based analyses both highlight new links between the acquired and inherited pathogenic, cardiac and inflammatory traits of sepsis/MetS. Those include the HOTAIR and MIAT lncRNAs and their targets, such as miR-122, -150, -155, -182, -197, -375, -608 and HLA-DRA. Implicating non-coding RNA regulators in sepsis and MetS may delineate novel high-value biomarkers and targets for intervention.
82
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 8.7K citations · Full text
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
John L. Rinn, Michael A. Kertesz, Jordon K. Wang et al. · Cell · 2007 · 4.2K citations · Full text
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai, Ohad Manor, Yue Wan et al. · Science · 2010 · 3.2K citations · Full text
C-Reactive Protein Levels and Outcomes after Statin Therapy
Paul M. Ridker, Christopher P. Cannon, David A. Morrow et al. · New England Journal of Medicine · 2005 · 2.3K citations · Full text